平滑肌肉瘤:全球臨床實驗檢討

本報告提供平滑肌肉瘤治療藥物的臨床實驗資料，彙整各國的趨勢，臨床實驗數，全球各臨床實驗中心的募集情況等資料，為您概述為以下內容。

目錄

簡介

• 平滑肌肉瘤
• 關於本報告

不同地區的臨床實驗

• 臨床實驗:各國
  • 亞太地區前幾名國家
  • 歐洲的前五國
  • 北美前幾名國家
  • 中東及非洲的前幾名國家
  • 中南美的主要國家

金磚四國的臨床實驗

G7各國的臨床實驗

G7各國的臨床實驗:各進展狀況

E7各國的臨床實驗

E7各國的臨床實驗:各進展狀況

各階段的臨床實驗

• 進行中的臨床實驗:各階段

臨床實驗:各臨床實驗狀態

未完成的臨床實驗

每段時期的實驗人數

有力的贊助商

• 主要的參與臨床實驗企業

潛力治療藥物比較

臨床實驗簡介

• 臨床實驗概要:主要企業
  • Janssen Research & Development LLC
  • Sarcoma Alliance for Research through Collaboration
  • Janssen Research & Development, LLC
  • 第一三共
  • Eisai公司
  • ArQule, Inc.
  • Oncolytics Biotech Inc.
  • Astex Pharmaceuticals, Inc.
  • ImClone LLC
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
• 臨床實驗概要:最高級大學 / 研究機關 / 醫院
  • Memorial Sloan Kettering Cancer Center
  • New York University School of Medicine
  • The University of Texas M. D. Anderson Cancer Center
  • Dana-Farber Cancer Institute
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Federation Nationale des Centres de Lutte Contre le Cancer
  • Princess Margaret Hospital
  • Mayo Clinic
  • Herbert Irving Comprehensive Cancer Center
  • University of Heidelberg
  • Case Comprehensive Cancer Center
  • Sidney Kimmel Comprehensive Cancer Center
  • Norris Cotton Cancer Center
  • Fred Hutchinson Cancer Research Center
  • The University of Chicago
  • Baylor College of Medicine
  • Wake Forest University
  • Northwestern University
  • American College of Surgeons
  • University of Pennsylvania

主要5件臨床實驗簡介

附錄

• 簡稱
• 定義
• 調查方法
• 二級研究
• 關於GlobalData
• 諮詢方式
• 免責聲明
• 資訊來源

圖表一覽

Abstract

GlobalData's clinical trial report, "Leiomyosarcoma Global Clinical Trials Review, H2, 2012" provides data on the Leiomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leiomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leiomyosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Leiomyosarcoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Leiomyosarcoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

• Table of Contents
  • List of Tables
  • List of Figures
• Introduction
  • Leiomyosarcoma
  • Report Guidance
• Clinical Trials by Region
• Clinical Trials by Country
  • Top Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
• Clinical Trials by BRIC Nations
• Clinical Trials by G7 Nations
• Clinical Trials in G7 Nations by Trial Status
• Clinical Trials by E7 Nations
• Clinical Trials in E7 Nations by Trial Status
• Clinical Trials by Phase
• In Progress Trials by Phase
• Clinical Trials by Trial Status
• Unaccomplished Trials of Leiomyosarcoma
• Subjects Recruited Over a Period of Time
• Prominent Sponsors
  • Top Companies Participating in Leiomyosarcoma Therapeutics Clinical Trials
• Prominent Drug Comparison
• Clinical Trial Profiles
  • Clinical Trial Overview of Top Companies
  • Janssen Research & Development LLC
  • Clinical Trial Overview of Janssen Research & Development LLC
  • Sarcoma Alliance for Research through Collaboration
  • Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration
  • Janssen Research & Development, LLC
  • Clinical Trial Overview of Janssen Research & Development, LLC
  • Daiichi Sankyo, Inc.
  • Clinical Trial Overview of Daiichi Sankyo, Inc.
  • Eisai Inc.
  • Clinical Trial Overview of Eisai Inc.
  • ArQule, Inc.
  • Clinical Trial Overview of ArQule, Inc.
  • Oncolytics Biotech Inc.
  • Clinical Trial Overview of Oncolytics Biotech Inc.
  • Astex Pharmaceuticals, Inc.
  • Clinical Trial Overview of Astex Pharmaceuticals, Inc.
  • ImClone LLC
  • Clinical Trial Overview of ImClone LLC
  • Merck & Co., Inc.
  • Clinical Trial Overview of Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Clinical Trial Overview of GlaxoSmithKline plc
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
  • Memorial Sloan Kettering Cancer Center
  • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
  • New York University School of Medicine
  • Clinical Trial Overview of New York University School of Medicine
  • The University of Texas M. D. Anderson Cancer Center
  • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
  • Dana-Farber Cancer Institute
  • Clinical Trial Overview of Dana-Farber Cancer Institute
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Federation Nationale des Centres de Lutte Contre le Cancer
  • Clinical Trial Overview of Federation Nationale des Centres de Lutte Contre le Cancer
  • Princess Margaret Hospital
  • Clinical Trial Overview of Princess Margaret Hospital
  • Mayo Clinic
  • Clinical Trial Overview of Mayo Clinic
  • Herbert Irving Comprehensive Cancer Center
  • Clinical Trial Overview of Herbert Irving Comprehensive Cancer Center
  • University of Heidelberg
  • Clinical Trial Overview of University of Heidelberg
  • Case Comprehensive Cancer Center
  • Clinical Trial Overview of Case Comprehensive Cancer Center
  • Sidney Kimmel Comprehensive Cancer Center
  • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
  • Norris Cotton Cancer Center
  • Clinical Trial Overview of Norris Cotton Cancer Center
  • Fred Hutchinson Cancer Research Center
  • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
  • The University of Chicago
  • Clinical Trial Overview of The University of Chicago
  • Baylor College of Medicine
  • Clinical Trial Overview of Baylor College of Medicine
  • Wake Forest University
  • Clinical Trial Overview of Wake Forest University
  • Northwestern University
  • Clinical Trial Overview of Northwestern University
  • American College of Surgeons
  • Clinical Trial Overview of American College of Surgeons
  • University of Pennsylvania
  • Clinical Trial Overview of University of Pennsylvania
• Five Key Clinical Profiles

Appendix

• Abbreviations
• Definitions
• Research Methodology
• Secondary Research
• About GlobalData
• Contact Us
• Disclaimer
• Source

• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Zone, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, BRIC Countries, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, G7 Countries, 2012*
• Leiomyosarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, E7 Countries, 2012*
• Leiomyosarcoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Phase, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Suspended Clinical Trials, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
• Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Research & Development LLC, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Research & Development, LLC, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncolytics Biotech Inc., 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Astex Pharmaceuticals, Inc., 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federation Nationale des Centres de Lutte Contre le Cancer, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Princess Margaret Hospital, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Herbert Irving Comprehensive Cancer Center, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Norris Cotton Cancer Center, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by American College of Surgeons, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012*

• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, G7 Countries (%), 2012*
• Leiomyosarcoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
• Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
• Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
• Leiomyosarcoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
• GlobalData Methodology